Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the ...

Medtronic issues recall diabetes software affecting CareLink version 4.2B due to incorrect glucose data display, prompting clinician review.

Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on Wednesday.

While insulin pumps and continuous glucose monitors have improved the lives of many Type 1 diabetes patients, some still ...

Nearly two years after submitting its MiniMed 780G insulin delivery system to the FDA for clearance, Medtronic is still awaiting the agency’s nod—though not for a lack of evidence to back the ...

As Medtronic continues to await FDA clearance of the latest iteration of its MiniMed insulin pump, the medtech giant has churned out a steady stream of data supporting the device’s ability to improve ...

170 cases of hyperglycemia and 11 cases of diabetic ketoacidosis reported between January 2023 and September 2024 in the US. FDA classifies recall as class I due to potential for serious health risks.

I recently had the chance to try out the latest in diabetes tech from Medtronic, conducting a 14-day test drive of the new Minimed Connect data display platform. This new system shows both insulin ...

On April 14, 2023, Medtronic MiniMed, Inc. and MiniMed Distribution Corp. (collectively “Medtronic Diabetes,” “Medtronic”) filed a notice of data breach with the Montana Attorney General after ...

Medtronic has reported 6.6% revenue growth to $9B in Q2 2026, led by its cardiovascular portfolio's 10.8% increase and 71% ...

Medtronic plc.'s MDT Diabetes Management segment is dominating the headlines of late. Following the company’s receipt of the CE Mark approval for its advanced continuous glucose monitoring (CGM) ...

Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on Wednesday.